Literature DB >> 8738473

Chronic proliferative dermatitis in mice: neutrophil-endothelium interactions and the role of adhesion molecules.

H I Gallardo Torres1, M J Gijbels, H HegnEsch, G Kraal.   

Abstract

The murine chronic proliferative dermatitis mutation (cpdm/cpdm) is characterized by epidermal hyperplasia and hyperproliferation of ventral and dorsal skin sites. The expression of endothelium-associated adhesion molecules was studied in combination with the binding capacity of various cell types on frozen sections of the affected skin. In correlation with the relative absence of lymphocytes in the cpdm/cpdm skin no lymphocyte binding could be observed, but avid adhesion of neutrophils was seen. Binding of neutrophils could be blocked with antibodies against L-selectin, LFA-1, CR3 and anti ICAM-1. No expression of vascular addressins or E-selectin on endothelium in the dermis was found. The cpdm/cpdm mutation has therefore characteristics of a psoriasis-like as well as a more generalized inflammatory skin condition.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8738473     DOI: 10.1159/000163970

Source DB:  PubMed          Journal:  Pathobiology        ISSN: 1015-2008            Impact factor:   4.342


  5 in total

1.  SHARPIN is a component of the NF-κB-activating linear ubiquitin chain assembly complex.

Authors:  Fuminori Tokunaga; Tomoko Nakagawa; Masaki Nakahara; Yasushi Saeki; Masami Taniguchi; Shin-ichi Sakata; Keiji Tanaka; Hiroyasu Nakano; Kazuhiro Iwai
Journal:  Nature       Date:  2011-03-31       Impact factor: 49.962

2.  Loss-of-function of SHARPIN causes an osteopenic phenotype in mice.

Authors:  Tian Xia; Yanhua Liang; Junrong Ma; Mi Li; Meng Gong; Xijie Yu
Journal:  Endocrine       Date:  2010-11-11       Impact factor: 3.633

3.  Defective immune responses in mice lacking LUBAC-mediated linear ubiquitination in B cells.

Authors:  Yoshiteru Sasaki; Soichi Sano; Masaki Nakahara; Shigeo Murata; Kohei Kometani; Yuichi Aiba; Shinji Sakamoto; Yoshihiro Watanabe; Keiji Tanaka; Tomohiro Kurosaki; Kazuhiro Iwai
Journal:  EMBO J       Date:  2013-08-13       Impact factor: 11.598

4.  SHARPIN negatively associates with TRAF2-mediated NFκB activation.

Authors:  Yanhua Liang
Journal:  PLoS One       Date:  2011-07-29       Impact factor: 3.240

5.  A rare functional variant of SHARPIN attenuates the inflammatory response and associates with increased risk of late-onset Alzheimer's disease.

Authors:  Yuya Asanomi; Daichi Shigemizu; Akinori Miyashita; Risa Mitsumori; Taiki Mori; Norikazu Hara; Kaoru Ito; Shumpei Niida; Takeshi Ikeuchi; Kouichi Ozaki
Journal:  Mol Med       Date:  2019-06-20       Impact factor: 6.354

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.